s6y

Nuo Therapeutics, Inc.

Ticker
AURX
CIK
1091596
Industry
Surgical & Medical Instruments & Apparatus
Formerly
Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC

Financials 118

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 118 financials filings

News 212

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 212 news filings

Ownership 512

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4/A Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 512 ownership filings

Prospectus 128

  1. S-3/A Registration statement for specified transactions by certain issuers
  2. S-3 Registration statement for specified transactions by certain issuers
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. SC TO-T/A Third party tender offer statement
  5. SC TO-T Third party tender offer statement
  6. RW Registration Withdrawal Request
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 128 prospectus filings

Proxies 34

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEF 14C Definitive information statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEF 14A Definitive proxy statements

All 34 proxies filings

Other 162

  1. SCHEDULE 13D/A
  2. SCHEDULE 13G/A
  3. SCHEDULE 13D/A
  4. D Exempt (Private) Offering
  5. EFFECT Notice of Effectiveness
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. D Exempt (Private) Offering
  9. D Exempt (Private) Offering
  10. D Exempt (Private) Offering

All 162 other filings